Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Thymmune Therapeutics is a biotechnology company developing a machine learning-driven thymic cell engineering platform.
InSilicoTrials provides in silico modeling and simulation tools that help researchers improve drug development using computational methods.
34 Lives strives to reduce this statistic to zero by providing innovative technology and services for the kidney transplant process.
Satio brings a dried blood spot and whole blood collection to the consumer; simple, painless, and clean using patches.
Medentum Innovations promotes health equity and transforming healthcare through affordable, high-performance point-of-care devices.
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies.
Cision Vision is a developer and seller of imaging medical devices.
Trace Biosciences creates fluorescence imaging agents for real-time nerve visualization during surgery.
ImmunoVec develops gene therapy treatments to cure terminal genetic diseases of the immune system.
Duracyte is a biotechnology business that develops implantable "living pharmacy" devices.
Landmark Bio is a biotechnology industry.
Steer Bio is a biotechnology company that specializes in revitalizing cell-based medicines.
Transposon Therapeutics specializes in developing therapeutics for debilitating and life-threatening diseases.
Seaport Therapeutics is a clinical-stage biopharmaceutical company that develops neuropsychiatric medicines.
Luminary Therapeutic is a cancer research center that develops pre-clinical stage cell therapy for cancer and autoimmune diseases.
Linnaeus Therapeutics is a development stage biotech company that develops and commercializes drugs for cancer.
Homeward is focused on improving access to high-quality, affordable primary and specialty care in rural communities.
Mission Mobile Medical provides mobile medical units at low costs.
BioCurie is developing an artificial intelligence software platform to better cell and gene therapy.
SecondWave Systems is an ultrasound stimulation platform.
Tiga TX develops an IgA therapeutic monoclonal antibody platform for the treatment of solid tumors.
SonALAsense develops SDT (Sonodynamic Therapy) intended to turn glioblastoma multiforme (GBM) patients into cancer survivors.
SynthX Center is a biomedical research center focused on developing drugs and health technologies.
Daré Bioscience is a biopharmaceutical company that develops and commercializes therapies for women's health.
Advanced Research Projects Agency for Health has invested in 47 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Advanced Research Projects Agency for Health's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 17 different industry categories.
Among tracked funding rounds, SonALAsense received $46.0M in a Grant round. Advanced Research Projects Agency for Health's total known invested capital is $768.3M.
Advanced Research Projects Agency for Health's average investment size is $17.9M across its portfolio of 47 companies.
Recent Advanced Research Projects Agency for Health portfolio additions include Thymmune Therapeutics, InSilicoTrials, 34 Lives, Satio, Medentum Innovations. These companies were founded in 2020 or later.